Get the Stockscreener App
56.27
2.55%
-1.47
Disc Medicine Inc stock is traded at $56.27, with a volume of 205.02K.
It is down -2.55% in the last 24 hours and up +4.77% over the past month.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
See More
Previous Close:
$57.74
Open:
$57.99
24h Volume:
205.02K
Relative Volume:
0.52
Market Cap:
$1.95B
Revenue:
-
Net Income/Loss:
$-91.00M
P/E Ratio:
-15.33
EPS:
-3.67
Net Cash Flow:
$-74.38M
1W Performance:
+6.23%
1M Performance:
+4.77%
6M Performance:
-6.95%
1Y Performance:
+14.30%
1-Day Range:
$55.77
$58.30
1-Week Range:
$53.38
$58.61
52-Week Range:
$30.82
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
(617) 674-9274
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
56.27 | 1.83B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.20 | 119.76B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.96 | 59.14B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.12 | 41.40B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
555.96 | 32.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.70 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jun-11-25 | Resumed | Raymond James | Strong Buy |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-04-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-23-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-01-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jun-07-23 | Initiated | H.C. Wainwright | Buy |
| May-17-23 | Initiated | Raymond James | Outperform |
| Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-21-23 | Initiated | Stifel | Buy |
| Apr-20-23 | Initiated | Morgan Stanley | Overweight |
| Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
How Disc Medicine Inc. stock performs during market volatilityFree Exclusive Access to Stock Gurus - Newser
What makes Disc Medicine Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser
Why Disc Medicine Inc. stock attracts strong analyst attentionShort Squeeze Radar - Newser
Disc medicine CFO Franchi sells $115k in stock By Investing.com - Investing.com Canada
Disc medicine CFO Franchi sells $115k in stock - Investing.com India
Disc Medicine, Inc. (NASDAQ:IRON) CEO Sells $1,925,484.00 in Stock - Defense World
Disc Medicine Appoints Nadim Ahmed To Board - citybiz
Disc Medicine appoints Nadim Ahmed to board of directors By Investing.com - Investing.com India
Disc Medicine Elects Nadim Ahmed as Director - TipRanks
Disc Medicine, Inc. Appoints Nadim Ahmed to Board of Directors - Nasdaq
Disc Medicine Appoints Nadim Ahmed to its Board of Directors - The Manila Times
Disc Medicine, Inc. Appoints Nadim Ahmed to Its Board of Directors - MarketScreener
Amalgamated Bank Purchases 219 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Morgan Stanley Assumes Coverage of Disc Medicine (IRON) With $85 PT - MSN
Disc Medicine,Inc. shares rise 1.54% after-hours as FibroBiologics advances cartilage repair program. - AInvest
Disc Medicine CEO Quisel sells $286k in shares By Investing.com - Investing.com South Africa
Disc Medicine CEO Quisel sells $286k in shares - Investing.com
How to Take Advantage of moves in (IRON) - news.stocktradersdaily.com
HC Wainwright Reiterates “Buy” Rating for Disc Medicine (NASDAQ:IRON) - Defense World
Morgan Stanley Begins Coverage on Disc Medicine (NASDAQ:IRON) - Defense World
Disc Medicine, Inc.(NasdaqGM: IRON) dropped from Russell Small Cap Comp Value Index - MarketScreener
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of “Buy” by Analysts - Defense World
Learn to Evaluate (IRON) using the Charts - news.stocktradersdaily.com
Leerink Partners Reiterates a Buy Rating on Disc Medicine (IRON) With an $85 Price Target - Yahoo Finance
Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright - MarketBeat
Disc Medicine's Bitopertin: A Breakthrough in Rare Disease Treatment and a Smart Play for Covered Calls - AInvest
Insider Sell: Jean Franchi Sells 2,000 Shares of Disc Medicine Inc (IRON) - GuruFocus
Disc Medicine (NASDAQ:IRON) Given Buy Rating at HC Wainwright - Defense World
Analysts Offer Predictions for Disc Medicine Q2 Earnings - Defense World
Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating - MSN
Disc Medicine stock price target maintained at $118 by H.C. Wainwright - Investing.com
Disc Medicine (IRON) Maintains Buy Rating and Price Target | IRO - GuruFocus
Disc Medicine (IRON) Maintains Buy Rating and Price Target | IRON Stock News - GuruFocus
Disc Medicine’s (IRON) Outperform Rating Reaffirmed at Wedbush - Defense World
First Week of December 19th Options Trading For Disc Medicine (IRON) - Nasdaq
Long Term Trading Analysis for (IRON) - news.stocktradersdaily.com
Disc Medicine shareholders vote on executive pay and board members By Investing.com - Investing.com Canada
Disc Medicine shareholders vote on executive pay and board members - Investing.com Australia
Disc Medicine Holds 2025 Annual Stockholders Meeting - TipRanks
Disc Medicine Presents Positive Clinical Data Updates Across Por - GuruFocus
Disc Medicine (IRON) Highlights Research Advances at EHA 2025 | - GuruFocus
Disc Medicine reports positive data from clinical programs at EHA By Investing.com - Investing.com South Africa
Disc Medicine reports positive data from clinical programs at EHA - Investing.com Australia
Disc Medicine Highlights Positive Clinical Data for Bitopertin, DISC-0974, and DISC-3405 at EHA 2025; Management to Host Corporate Update Call - Nasdaq
Disc Medicine Presents Positive Clinical Data Updates - GlobeNewswire
Disc Medicine Reports Breakthrough Clinical Data Across 3 Blood Disease Programs | IRON Stock News - Stock Titan
Disc Medicine (NASDAQ:IRON) Now Covered by Analysts at Raymond James - Defense World
Disc Medicine Inc Stock (IRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):